Accordingly, all TD cells were able to trigger Thr68 phosphorylation after treatment, but the persistence of its phosphorylation 24 h post bleomycin exposure might demonstrate the incapacity of TD cells to fully activate CHK2. The gene discussed is CHEK2; the disease is thanatophoric dysplasia.